Andrea Kolbus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Kolbus has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Friedrich Nagele
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
2 shared publicationsGertrud Unfried
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
2 shared publicationsJohannes C. Huber
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
2 shared publicationsKatharina Walch
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
2 shared publicationsA. Radjabi
1 shared publicationC. Matthai
Department of Gynecological Endocrinology and Reproductive Medicine, Medical University of Vienna, Waehringer Guertel, Vienna, Austria
1 shared publication
Latest Publications
- Open Access
- 22 April 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 1-7
OCT-4 expression in follicular and luteal phase endometrium: a pilot study
Background: The stem cell marker Octamer-4 (OCT-4) is expressed in human endometrium. Menstrual cycle-dependency of OCT-4 expression has not been investigated to date. Methods: In a prospective, single center cohort study of 98 women undergoing hysteroscopy during the follicular (n = 49) and the luteal (n = 40) phases of the menstrual cycle, we obtained endometrial samples. Specimens were investigated for OCT-4 expression on the mRNA and protein levels using reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. Expression of OCT-4 was correlated to menstrual cycle phase. Results: Of 89 women sampled, 49 were in the follicular phase and 40 were in the luteal phase. OCT-4 mRNA was detected in all samples. Increased OCT-4 mRNA levels in the follicular and luteal phases was found in 35/49 (71%) and 27/40 (68%) of women, respectively (p = 0.9). Increased expression of OCT-4 protein was identified in 56/89 (63%) samples. Increased expression of OCT-4 protein in the follicular and luteal phases was found in 33/49 (67%) and 23/40 (58%) of women, respectively (p = 0.5). Conclusions: On the mRNA and protein levels, OCT-4 is not differentially expressed during the menstrual cycle. Endometrial OCT-4 is not involved in or modulated by hormone-induced cyclical changes of the endometrium.
- 22 April 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 1-7
Open AccessOCT-4 expression in follicular and luteal phase endometrium: a pilot study
Background: The stem cell marker Octamer-4 (OCT-4) is expressed in human endometrium. Menstrual cycle-dependency of OCT-4 expression has not been investigated to date. Methods: In a prospective, single center cohort study of 98 women undergoing hysteroscopy during the follicular (n = 49) and the luteal (n = 40) phases of the menstrual cycle, we obtained endometrial samples. Specimens were investigated for OCT-4 expression on the mRNA and protein levels using reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. Expression of OCT-4 was correlated to menstrual cycle phase. Results: Of 89 women sampled, 49 were in the follicular phase and 40 were in the luteal phase. OCT-4 mRNA was detected in all samples. Increased OCT-4 mRNA levels in the follicular and luteal phases was found in 35/49 (71%) and 27/40 (68%) of women, respectively (p = 0.9). Increased expression of OCT-4 protein was identified in 56/89 (63%) samples. Increased expression of OCT-4 protein in the follicular and luteal phases was found in 33/49 (67%) and 23/40 (58%) of women, respectively (p = 0.5). Conclusions: On the mRNA and protein levels, OCT-4 is not differentially expressed during the menstrual cycle. Endometrial OCT-4 is not involved in or modulated by hormone-induced cyclical changes of the endometrium.
- 1 April 2007
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 73 (2) , 188-193
Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome
- 1 April 2007
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 73 (2) , 188-193
Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome
- 28 February 2006
- Published by Elsevier in Fertility and Sterility
- Vol. 85 (2) , 523-525
A polymorphism of the interleukin 1 receptor antagonist is not associated with polycystic ovary syndrome in Caucasian women
- 28 February 2006
- Published by Elsevier in Fertility and Sterility
- Vol. 85 (2) , 523-525
A polymorphism of the interleukin 1 receptor antagonist is not associated with polycystic ovary syndrome in Caucasian women
- Open Access
- 1 January 2006
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 12 (1) , 7-10
Oct-4 expression in human endometrium
The transcription factor Oct-4 is crucial for the maintenance of cell pluripotency and is known to be expressed in embryonic stem cells, germ cells and whole embryos at various stages of development. Oct-4 regulates cell fate in a dose-dependent manner and plays a key role in germ-cell tumours. In the past, several stem-cell markers have been detected, and their role in the pathogenesis of diseases has been discussed frequently. Thus, we investigated the expression of Oct-4 comparing its occurrence in endometrium of healthy and diseased women using immunohistochemistry (IHC) and RT–PCR. IHC demonstrated Oct-4 expression in 25 of 60 sections (42%), respectively in 11 out of 25 patients (44%). Oct-4 mRNA was detected by RT–PCR in all tested samples (9 of 9) of endometrium, although the levels of expression varied. To our knowledge, this is the first study demonstrating Oct-4 expression in human endometrium.
- 1 January 2006
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 12 (1) , 7-10
Open AccessOct-4 expression in human endometrium
The transcription factor Oct-4 is crucial for the maintenance of cell pluripotency and is known to be expressed in embryonic stem cells, germ cells and whole embryos at various stages of development. Oct-4 regulates cell fate in a dose-dependent manner and plays a key role in germ-cell tumours. In the past, several stem-cell markers have been detected, and their role in the pathogenesis of diseases has been discussed frequently. Thus, we investigated the expression of Oct-4 comparing its occurrence in endometrium of healthy and diseased women using immunohistochemistry (IHC) and RT–PCR. IHC demonstrated Oct-4 expression in 25 of 60 sections (42%), respectively in 11 out of 25 patients (44%). Oct-4 mRNA was detected by RT–PCR in all tested samples (9 of 9) of endometrium, although the levels of expression varied. To our knowledge, this is the first study demonstrating Oct-4 expression in human endometrium.